Pharmaceutical retailers operate pharmacy chains that fill prescriptions, sell over-the-counter health products and increasingly provide clinical services — vaccinations, testing and chronic disease management. Prescription dispensing is the core business, driven by the number of prescriptions filled and the reimbursement rates paid by pharmacy benefit managers (PBMs), insurers and government programs. PBM pricing power has become the dominant profitability challenge for pharmacy chains, with reimbursement rates declining persistently as PBMs negotiate harder on behalf of their payer clients. Front-of-store retail — general merchandise, beauty, snacks — provides additional revenue but faces intense competition from mass retail and e-commerce. Pharmacy automation reduces labor cost per prescription but requires capital investment. Clinic-in-pharmacy models provide additional revenue streams and drive prescription loyalty. For investors, pharmacy chains face structural margin pressure from PBM reimbursement dynamics that are difficult to fully offset, and the long-term investment thesis depends on the ability to grow into healthcare services revenue that carries better economics than commoditized prescription dispensing.
